Respiratory Distress Syndrome (RDS)

01Pathophysiology

Surfactant is a phospholipid-protein complex produced by type II pneumocytes beginning around 24 weeks of gestation, but reaching adequate levels only near 34 to 36 weeks. Its primary function is to reduce alveolar surface tension at the air-liquid interface, thereby preventing alveolar collapse at end-expiration. The dominant phospholipid component is dipalmitoylphosphatidylcholine (DPPC, also called lecithin), and the key surfactant proteins are SP-B and SP-C, which facilitate surfactant spreading and adsorption.

In a premature infant, type II pneumocytes are structurally and functionally immature. They cannot produce sufficient surfactant. Without surfactant, alveolar surface tension increases dramatically, leading to widespread atelectasis (alveolar collapse) at end-expiration. This collapse reduces the functional residual capacity (FRC) of the lungs, meaning the neonate must generate enormous inspiratory pressures with each breath just to re-expand collapsed alveoli. This is why you see grunting: the infant is exhaling against a partially closed glottis to create auto-PEEP, an instinctive attempt to maintain alveolar patency.

The atelectasis creates significant ventilation-perfusion (V/Q) mismatch and intrapulmonary shunting. Blood passes through non-ventilated alveoli without gas exchange, resulting in hypoxemia and hypercarbia. The resulting hypoxia and acidosis cause pulmonary vasoconstriction, which further reduces pulmonary blood flow, worsens gas exchange, and damages the alveolar epithelium. Damaged capillaries leak proteinaceous fluid into the alveolar space, which forms eosinophilic hyaline membranes on histology, hence the historical name "hyaline membrane disease."

This creates a vicious cycle: surfactant deficiency leads to atelectasis, which leads to hypoxia, which leads to epithelial injury, which further impairs any residual surfactant production. Without intervention, the cycle progresses to respiratory failure.

Why does maternal diabetes increase risk? Fetal hyperinsulinemia (driven by maternal hyperglycemia crossing the placenta) directly inhibits the production of surfactant phospholipids. Insulin antagonizes the stimulatory effect of cortisol on type II pneumocyte maturation. So even at equivalent gestational ages, infants of diabetic mothers have less mature lungs.

Why does cesarean delivery without labor increase risk? The process of labor itself triggers a catecholamine surge and cortisol release in the fetus, which stimulates surfactant secretion and promotes lung fluid absorption. A scheduled cesarean section performed before labor onset bypasses this hormonal preparation.

Protective factors are worth noting because they appear as distractors. Chronic intrauterine stress (such as preeclampsia, intrauterine growth restriction, or prolonged rupture of membranes) actually accelerates fetal lung maturation through sustained cortisol exposure, reducing RDS risk.

02Classification and Clinical Manifestation

RDS severity is graded clinically and radiographically. The Silverman-Andersen score is used to assess clinical severity at the bedside, while chest X-ray findings are staged by the degree of opacification.

Clinical Severity (Silverman-Andersen Retraction Score)

A total score of 0 indicates no distress; a score of 7 to 10 indicates severe respiratory distress requiring immediate intervention.

Radiographic Staging

Temporal Course of Clinical Features

03Diagnostic Workup

The chest X-ray is the best initial test and the cornerstone of diagnosis. In a premature neonate presenting with early-onset respiratory distress, bilateral ground-glass opacities with air bronchograms on chest X-ray are virtually diagnostic. Air bronchograms appear because the air-filled bronchi become visible against the backdrop of collapsed, opacified alveoli. Lung volumes are characteristically low because of diffuse atelectasis. This pattern is uniform and bilateral, which helps distinguish RDS from focal processes like pneumonia.

An arterial blood gas is obtained to quantify the severity of gas exchange impairment. You will see hypoxemia with a widened alveolar-arterial ($A\text{-}aA\backslash text\{-\}a$) oxygen gradient, confirming intrapulmonary shunting. Progressive hypercarbia indicates ventilatory failure and suggests the need for mechanical ventilation.

The L/S ratio is a prenatal test performed on amniotic fluid (obtained via amniocentesis). An L/S ratio $\ge \backslash geq$ 2.0 indicates mature surfactant production. The presence of phosphatidylglycerol (PG) is an additional marker that confirms lung maturity. PG appears late in gestation (around 35 to 36 weeks) and is not affected by blood or meconium contamination, making it a more reliable marker when the amniotic fluid sample is contaminated. Importantly, PG is absent in immature lungs regardless of the L/S ratio, so the combination of L/S < 2.0 and absent PG is highly predictive of RDS.

A sepsis workup (CBC with differential, blood culture, and sometimes C-reactive protein) must be performed because neonatal pneumonia (particularly Group B Streptococcus) can present identically. These two conditions can coexist, and you cannot distinguish them on chest X-ray alone in many cases. Empiric antibiotics (typically ampicillin + gentamicin) are often started until cultures return negative.

04Management and Treatment

Prevention is the highest-yield testable concept in RDS management. Antenatal corticosteroids are the single most effective intervention to reduce both the incidence and severity of RDS. Betamethasone is preferred because it crosses the placenta effectively and has a longer duration of action compared to other corticosteroids. The standard regimen is 12 mg intramuscularly every 24 hours for 2 doses, administered to the mother when preterm delivery between 24 and 34 weeks is anticipated. The benefit is optimal when delivery occurs more than 24 hours but less than 7 days after the first dose. Corticosteroids accelerate type II pneumocyte maturation and stimulate surfactant synthesis.

If the neonate is born and develops RDS, the next step is respiratory support. The current approach favors early nasal CPAP, which maintains alveolar patency by providing constant distending pressure. CPAP splints the alveoli open at end-expiration (similar to what the infant's own grunting attempts to achieve, but more effectively). Many centers now practice the INSURE technique (Intubate, Surfactant, Extubate to CPAP), which delivers surfactant while minimizing the duration of mechanical ventilation. An emerging alternative is the LISA technique (Less Invasive Surfactant Administration), where surfactant is delivered through a thin catheter while the infant remains on CPAP, avoiding intubation entirely.

Exogenous surfactant is the definitive treatment. It is administered directly into the trachea via an endotracheal tube. Poractant alfa (a porcine-derived natural surfactant) at an initial dose of 200 mg/kg has been shown to produce a faster and more sustained response compared to beractant (bovine-derived) at 100 mg/kg. After administration, there is typically a rapid improvement in oxygenation and lung compliance within minutes.

Mechanical ventilation is reserved for infants who fail CPAP. Indications include persistent $Fi{O}_{2}FiO\_2$ requirement above 0.40 to maintain target saturations, recurrent apnea, or worsening respiratory acidosis (, $PaC{O}_2>60PaCO\_2\; >\; 60$ mmHg). Gentle ventilation strategies using low tidal volumes (4 to 6 mL/kg) and permissive hypercapnia ($PaC{O}_{2}PaCO\_2$ targets of 45 to 55 mmHg) are preferred to minimize ventilator-induced lung injury, which is a precursor to bronchopulmonary dysplasia (BPD).

Oxygen must be carefully titrated. The target $Sp{O}_{2}SpO\_2$ in preterm infants is 90 to 95%. Excessive oxygen (hyperoxia) increases the risk of retinopathy of prematurity (ROP) and contributes to oxidative lung injury. Insufficient oxygen increases mortality. This narrow therapeutic window is a frequently tested concept.

Complications to Anticipate

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The most common way students lose points on RDS questions is by confusing it with transient tachypnea of the newborn (TTN). Both present with respiratory distress shortly after birth and are associated with cesarean delivery. The critical discriminator is gestational age and chest X-ray pattern: RDS occurs in premature infants and shows ground-glass opacities with low lung volumes, while TTN occurs in term or near-term infants and shows hyperinflated lungs with perihilar streaking and fluid in the fissures. If the vignette describes a 28-week neonate with grunting and ground-glass opacities, that is RDS. If it describes a 38-week infant born via elective cesarean with tachypnea and streaky perihilar markings that resolve in 48 hours, that is TTN.

Another common trap involves maternal diabetes. Students often assume that a large-for-gestational-age (LGA) baby of a diabetic mother is "healthy" because of the large size. In reality, the fetal hyperinsulinemia delays surfactant maturation, putting this infant at higher risk for RDS even at later gestational ages than expected.

Watch for questions testing the timing of antenatal corticosteroids. The benefit requires at least 24 hours to take effect. If a mother presents in active preterm labor and delivers within 2 hours, the corticosteroids will not have had time to work. The vignette may present this scenario and then ask about the neonate's risk for RDS, and the answer is that the risk remains elevated despite receiving the first dose.

Finally, understand the oxygen management principle. A question may present an improving preterm infant on supplemental oxygen and ask about the target $Sp{O}_{2}SpO\_2$. The answer is 90 to 95%. Targeting higher saturations (> 95%) increases retinopathy of prematurity risk, while targeting lower saturations (< 85%) increases mortality. This narrow range is a favorite testing point, and students who default to "normal" adult oxygen saturation goals will choose the wrong answer.

The core competency being tested across all RDS questions is the ability to integrate gestational age, clinical presentation, radiographic findings, and the pathophysiology of surfactant deficiency into a coherent clinical picture, and then to sequence the management correctly: prevent with corticosteroids, support with CPAP, treat with surfactant, and escalate to mechanical ventilation only when necessary.